Close Menu

NEW YORK – Drawbridge Health announced today it has received 510(k) clearance from the US Food and Drug Administration for its OneDraw A1C Test System, which includes a blood collection device and HbA1c test.

The Menlo Park, California-based company developed the OneDraw Blood Collection Device to replace traditional needle or fingerstick blood draws. Instead, the device is placed on the upper arm and uses lancets to suction blood out of the arm and store it in a removable cartridge, making transportation of samples easier.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.